Contents

Glossary

• 1.8 NDPSC working parties
  • 1.8.1 Trans-Tasman Harmonisation Working Party
    • 1.8.1.2 Matters arising from NDPSC (39th meeting) consideration of TTHWP items
      • 1.8.1.2.1 Fluorides
      • 1.8.1.2.2 Promethazine
      • 1.8.1.2.3 Meclozine
      • 1.8.1.2.4 Dimenhydrinate
      • 1.8.1.2.5 Sedating antihistamines/codeine
      • 1.8.1.2.6 Amphotericin
• 1.9 Proposed routine changes to the SUSDP

Proposed changes/additions to Parts 1 to 3 and Part 5 of the Standard for the Uniform Scheduling of Drugs and Poisons

• 2.1 SUSDP, Part 1
• 2.2 SUSDP, Part 2
• 2.3 SUSDP, Part 3
• 2.4 SUSDP, Part 5

Agricultural/Veterinary, Industrial and Domestic Chemicals

• 3. Matters arising from the minutes of the previous meeting (consideration of post-meeting submissions under 42ZCZ)
  • 3.1 Packaging of S8 products
• 4. Other outstanding matters from previous meetings
  • 4.1 Child resistant packaging definition
  • 4.2 Naphthalene
  • 4.3 Home garden products - consideration of pack sizes
  • 4.5 Methylcyclopentadienyl manganese tricarbonyl
  • 4.6 Methylcyclopropene

5. Proposed changes/additions to the Standard for the Uniform Scheduling of Drugs and Poisons

• 5.1 SUSDP, Part 4
  • 5.1.1 Star anise oil and anise oil
  • 5.1.2 Creosote and related compounds and fractions
  • 5.1.3 Diethylene glycol butyl ether
  • 5.1.4 10,10'-Oxydiphenoxarsine
  • 5.1.5 Isohexadecane and isododecane
  • 5.1.6 Sodium dichloroisocyanurate
  • 5.1.7 Alkaline salts
• 5.2 SUSDP, Part 5
  • 5.2.1 Warning statements and general safety directions established by Office of Chemical Safety for agricultural and veterinary chemicals (standing agenda item)

6. Matters referred by the Australian Pesticides and Veterinary Medicines Authority

• 6.1 Ethoxysulfuron
• 6.2 Imidacloprid and moxidectin
• 6.3 Ethyl formate
• 6.4 Pyridalyl
• 6.5 Procymidone
• 6.6 Helicoverpa armigera
• 6.7 Pine oil

Top of page

7. Matters referred by Office of Chemical Safety (OCS) Branch

8. Antibiotics for consideration following recommendations of the Joint Expert Technical Advisory Committee on Antibiotic Resistance (JETACAR)

• 8.1 Virginiamycin
• 8.2 Tiamulin
• 8.3 Diaveridine
• 8.4 Neomycin
• 8.5 Roxarsone
• 8.6 Penethamate

Top of page

Pharmaceuticals

12. Matters arising from the minutes of the previous meeting (consideration of post-meeting submissions under 42ZCZ)

• 12.1 Pyridoxine
• 12.2 Orlistat
• 12.3 Nicotine in NRT
• 12.4 Paracetamol
• 12.5 Aspirin
• 12.6 Aripiprazole

13. Other outstanding matters from previous meetings

• 13.1 Melia azedarach
• 13.2 Mitragyna speciosa
• 13.3 Hyoscyamus niger
• 13.4 Mercury
• 13.5 Porcine pancreatic enzyme extract products
• 13.6 Pseudoephedrine
• 13.10 3,4-methylenedioxy-n, a-dimethylphenylethylamine (MDMA)
• 13.13 Kava and kavalactones
• 13.14 Nicotine in lozenges

Top of page

14. Proposed changes/additions to the Standard for the Uniform Scheduling of Drugs and Poisons

• 14.1 SUSDP, Part 4
  • 14.1.1 Sodium fluoride mouthwash
  • 14.1.2 Triamcinolone
• 14.2 SUSDP, Part 5
  • 14.2.1 Appendix H

15. Matters referred by the Australian Drug Evaluation Committee (ADEC)

• 15.1 New substances
  • 15.1.1 Adalimumab
  • 15.1.2 Enfuvirtide
  • 15.1.3 Escitalopram
  • 15.1.4 Cholera vaccine
  • 15.1.5 Adefovir dipivoxil
  • 15.1.6 Levosimendan
• 15.2 For information (substances already scheduled)
• 15.3 Other ADEC matters for consideration
  • 15.3.1 Quinine

16. Other matters for consideration

• 16.1 Temazepam

Information items (pharmaceuticals)

• 22. Amendments to the SUSDP
  • 22.1 Editorial changes and errata
    • 22.1.1 Mometasone and moxidectin
    • 22.1.2 NZ Poisons Information Centre information line
    • 22.1.3 Halofuginone

24. Attachments

• Attachment 2 - Case reports of naphthalene poisoning (Item 4.2)